CIK: 0001634557
申报总市值
—
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABBV | Abbvie INC | 股票-医疗保健 | 28.12% | — | -5.38% | |
| 2 | PRTA | Prothena Corporation plc | 股票-其他 | 24.96% | — | -0.03% | |
| 3 | REYN | Reynolds Consumer Products Inc. | 股票-其他 | 14.50% | — | -18.39% | |
| 4 | ALKS | Alkermes plc | 股票-医疗保健 | 14.35% | — | +0.18% | |
| 5 | TBPH | Theravance Biopharma, Inc. | 股票-其他 | 13.78% | -71.30% | EXIT | |
| 6 | BIIB | Biogen INC | 股票-医疗保健 | 2.16% | — | +752.15% | |
| 7 | GILD | Gilead Sciences INC | 股票-医疗保健 | 1.56% | — | — | |
| 8 | NWBO | Northwest Biotherapeutics | 股票-其他 | 0.57% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | PRTA | Prothena Corporation plc | +8% | -0.03% | 减仓 |
| 2 | TBPH | Theravance Biopharma, Inc. | +4.5% | +7.71% | 加仓 |
| 3 | BIIB | Biogen INC | +1.9% | +752.15% | 加仓 |
| 4 | NWBO | Northwest Biotherapeutics | -0.1% | — | 不变 |
| 5 | ALKS | Alkermes plc | -1% | +0.18% | 加仓 |
| 6 | ABBV | Abbvie INC | -5.8% | -5.38% | 减仓 |
| 7 | REYN | Reynolds Consumer Products Inc. | -9.1% | -18.39% | 减仓 |
| 8 | GILD | Gilead Sciences INC | — | NEW | 新建仓 |